253 related articles for article (PubMed ID: 24981932)
1. PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer.
Shinmura K; Kurabe N; Goto M; Yamada H; Natsume H; Konno H; Sugimura H
Mol Biol Rep; 2014 Oct; 41(10):6635-44. PubMed ID: 24981932
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse.
Coelho PA; Bury L; Shahbazi MN; Liakath-Ali K; Tate PH; Wormald S; Hindley CJ; Huch M; Archer J; Skarnes WC; Zernicka-Goetz M; Glover DM
Open Biol; 2015 Dec; 5(12):150209. PubMed ID: 26701933
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability.
Holland AJ; Lan W; Niessen S; Hoover H; Cleveland DW
J Cell Biol; 2010 Jan; 188(2):191-8. PubMed ID: 20100909
[TBL] [Abstract][Full Text] [Related]
4. Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stability.
Kim DH; Ahn JS; Han HJ; Kim HM; Hwang J; Lee KH; Cha-Molstad H; Ryoo IJ; Jang JH; Ko SK; Yang JO; Lee HG; Lee S; Song EJ; Kim JY; Huh YH; Kwon YT; Soung NK; Kim BY
Cell Death Dis; 2019 Jul; 10(8):570. PubMed ID: 31358734
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the PLK4 Gene as a Novel Strategy for the Treatment of Autosomal Recessive Microcephaly by Improving Centrosomal Dysfunction.
Xu YS; Su ZY; Sun L; Yang XM; Sun SY; Ji XF; Ji YZ; Zhang SQ; Tian J; Wu QC
J Mol Neurosci; 2021 Dec; 71(12):2618-2627. PubMed ID: 34272646
[TBL] [Abstract][Full Text] [Related]
7. Asterless is a scaffold for the onset of centriole assembly.
Dzhindzhev NS; Yu QD; Weiskopf K; Tzolovsky G; Cunha-Ferreira I; Riparbelli M; Rodrigues-Martins A; Bettencourt-Dias M; Callaini G; Glover DM
Nature; 2010 Oct; 467(7316):714-8. PubMed ID: 20852615
[TBL] [Abstract][Full Text] [Related]
8. Loss of AMPKalpha1 Triggers Centrosome Amplification via PLK4 Upregulation in Mouse Embryonic Fibroblasts.
Zhao Q; Coughlan KA; Zou MH; Song P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316320
[TBL] [Abstract][Full Text] [Related]
9. Loss of KLF14 triggers centrosome amplification and tumorigenesis.
Fan G; Sun L; Shan P; Zhang X; Huan J; Zhang X; Li D; Wang T; Wei T; Zhang X; Gu X; Yao L; Xuan Y; Hou Z; Cui Y; Cao L; Li X; Zhang S; Wang C
Nat Commun; 2015 Oct; 6():8450. PubMed ID: 26439168
[TBL] [Abstract][Full Text] [Related]
10. Autophosphorylation of polo-like kinase 4 and its role in centriole duplication.
Sillibourne JE; Tack F; Vloemans N; Boeckx A; Thambirajah S; Bonnet P; Ramaekers FC; Bornens M; Grand-Perret T
Mol Biol Cell; 2010 Feb; 21(4):547-61. PubMed ID: 20032307
[TBL] [Abstract][Full Text] [Related]
11. PLK4: a promising target for cancer therapy.
Zhao Y; Wang X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2413-2422. PubMed ID: 31492983
[TBL] [Abstract][Full Text] [Related]
12. The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.
Holland AJ; Fachinetti D; Zhu Q; Bauer M; Verma IM; Nigg EA; Cleveland DW
Genes Dev; 2012 Dec; 26(24):2684-9. PubMed ID: 23249732
[TBL] [Abstract][Full Text] [Related]
13. Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome.
Cizmecioglu O; Arnold M; Bahtz R; Settele F; Ehret L; Haselmann-Weiss U; Antony C; Hoffmann I
J Cell Biol; 2010 Nov; 191(4):731-9. PubMed ID: 21059844
[TBL] [Abstract][Full Text] [Related]
14. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
[TBL] [Abstract][Full Text] [Related]
15. KAT2A/KAT2B-targeted acetylome reveals a role for PLK4 acetylation in preventing centrosome amplification.
Fournier M; Orpinell M; Grauffel C; Scheer E; Garnier JM; Ye T; Chavant V; Joint M; Esashi F; Dejaegere A; Gönczy P; Tora L
Nat Commun; 2016 Oct; 7():13227. PubMed ID: 27796307
[TBL] [Abstract][Full Text] [Related]
16. Centriole duplication: A lesson in self-control.
Holland AJ; Lan W; Cleveland DW
Cell Cycle; 2010 Jul; 9(14):2731-6. PubMed ID: 20647763
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis.
Holland AJ; Fachinetti D; Da Cruz S; Zhu Q; Vitre B; Lince-Faria M; Chen D; Parish N; Verma IM; Bettencourt-Dias M; Cleveland DW
Mol Biol Cell; 2012 May; 23(10):1838-45. PubMed ID: 22456511
[TBL] [Abstract][Full Text] [Related]
18. The SCF/Slimb ubiquitin ligase limits centrosome amplification through degradation of SAK/PLK4.
Cunha-Ferreira I; Rodrigues-Martins A; Bento I; Riparbelli M; Zhang W; Laue E; Callaini G; Glover DM; Bettencourt-Dias M
Curr Biol; 2009 Jan; 19(1):43-9. PubMed ID: 19084407
[TBL] [Abstract][Full Text] [Related]
19. Chronic centrosome amplification without tumorigenesis.
Vitre B; Holland AJ; Kulukian A; Shoshani O; Hirai M; Wang Y; Maldonado M; Cho T; Boubaker J; Swing DA; Tessarollo L; Evans SM; Fuchs E; Cleveland DW
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6321-30. PubMed ID: 26578792
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Polo-like Kinase 4 Inhibitors for the Treatment of Cancer: A Mini Patent Review.
Shu Y; Liu Y; Bian S; Xie Z; Liao C
Mini Rev Med Chem; 2023; 23(1):67-79. PubMed ID: 35657046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
